Post-Acute COVID-19 Syndrome Clinical Trials

16 recruiting

Post-Acute COVID-19 Syndrome Trials at a Glance

16 actively recruiting trials for post-acute covid-19 syndrome are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Alexandroupoli, Amman, and Athens. Lead sponsors running post-acute covid-19 syndrome studies include University of Nove de Julho, Columbia University, and Changhai Hospital.

Browse post-acute covid-19 syndrome trials by phase

Treatments under study

About Post-Acute COVID-19 Syndrome Clinical Trials

Looking for clinical trials for Post-Acute COVID-19 Syndrome? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Post-Acute COVID-19 Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Post-Acute COVID-19 Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Long COVID Brain Fog: Cognitive Rehabilitation Trial

Cognitive ImpairmentCognitive DysfunctionPost-Acute COVID-19 Syndrome+2 more
University of Alabama at Birmingham30 enrolled1 locationNCT06095297
Recruiting
Not Applicable

Exercise Training Using an App on Physical Cardiovascular Function Individuals With Post-covid-19 Syndrome

Post-Acute COVID-19 Syndrome
University of Nove de Julho60 enrolled1 locationNCT06168006
Recruiting
Phase 2

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

Post-Acute COVID-19 SyndromePostural Tachycardia Syndrome (POTS)
Vanderbilt University Medical Center50 enrolled1 locationNCT07189936
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+14 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting

Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

Post-Acute COVID-19 Syndrome
Hospices Civils de Lyon150 enrolled2 locationsNCT07356570
Recruiting
Not Applicable

Brain-Training Treatment for Long COVID in Older Adults

Post-Acute COVID-19 Syndrome
UConn Health40 enrolled1 locationNCT05705193
Recruiting
Phase 2Phase 3

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

Post-Acute COVID-19 SyndromeLong COVIDPost-Acute COVID-19
Hellenic Institute for the Study of Sepsis182 enrolled24 locationsNCT05926505
Recruiting
Not Applicable

Care for Veterans Post-COVID-19

Post-Acute COVID-19 Syndrome
VA Office of Research and Development348 enrolled1 locationNCT05787379
Recruiting
Not Applicable

IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

Depressive DisorderPost-Acute COVID-19 Syndrome
Max-Planck-Institute of Psychiatry42 enrolled1 locationNCT07197138
Recruiting
Not Applicable

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Post-Acute COVID-19 SyndromeLong COVIDLong Covid19+3 more
Columbia University400 enrolled1 locationNCT07140094
Recruiting
Not Applicable

Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome

FatiguePost-Acute COVID-19 Syndrome
University of Maryland, Baltimore56 enrolled1 locationNCT05977179
Recruiting
Phase 2Phase 3

A Study of Apabetalone in Subjects With Long -COVID

Post-Acute COVID-19 Syndrome
Resverlogix Corp200 enrolled3 locationsNCT06590324
Recruiting

Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil

Post-Acute COVID-19 Syndrome
Inova Medical1,694 enrolled1 locationNCT05822193
Recruiting

Dysfunctional Breathing in Post COVID-19 Condition.

Post-Acute COVID-19 SyndromeDysfunctional BreathingBreathing Pattern Disorder+1 more
Karolinska Institutet200 enrolled2 locationsNCT06776263
Recruiting
Not Applicable

Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-COVID-19 Syndrome

Post-Acute COVID-19 Syndrome
University of Nove de Julho40 enrolled1 locationNCT06248151
Recruiting
Phase 1Phase 2

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

Post-Acute COVID-19 SyndromeLong COVID
Changhai Hospital76 enrolled1 locationNCT06492798